Tenderwize
Back to tender search

Open-house rebate agreements for Xipamid

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jan 03, 2028 · 505 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Xipamid, ATC C03BA10

58/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

58 / 100

Complexity

42 / 100

Risk factors

The notice says the model is open-house and not subject to ordinary procurement selection logic, which may affect legal...

Documents must be submitted through the DTVP communication area, not the offer area; paper originals must be in duplica...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Feb 2028
  • Non-exclusive pharmaceutical rebate agreements for the active substance Xipamid (ATC C03BA10).
  • Open-house model with identical, pre-set contract terms and no individual negotiation.
Show full summary

This is an open-house pharmaceutical supply arrangement for Xipamid (ATC C03BA10) led by AOK Bayern. It is not a competitive award procedure in the usual sense: all interested pharmaceutical companies that meet the stated eligibility condition can join on identical, non-negotiable terms. The contract period runs from 01.03.2026 to 29.02.2028, with contract entry possible until 03.01.2028. Submission is via DTVP electronic portal with a qualified electronic signature or by signed paper originals in duplicate; German language is required, and non-German documents must be submitted with German translation.

Risks

The notice says the model is open-house and not subject to ordinary procurement selection logic, which may affect legal...

Documents must be submitted through the DTVP communication area, not the offer area; paper originals must be in duplica...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The contract and annex 'Determination of the contract products' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability must be submitted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house rebate agreements for Xipamid

Open-house supply arrangement for pharmaceutical rebate agreements concerning Xipamid (ATC C03BA10). The lot is described as a non-exclusive, identical, non-negotiable contract model for all eligible pharmaceutical companies. Performance is in Germany, Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Feb 2026 - Feb 2028

Category

Pharmaceutical products

Deadline

Deadline Jan 03, 2028

Procurement Details

Publication date
13 Jan 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
23964-2026

Documents (2)

Similar tenders